Neurotrope, Inc. Contracts & Agreements
102 Contracts & Agreements
- Business Finance (34 contracts)
- Business Operations (10)
- Human Resources (22)
- Intellectual Property (1)
- Mergers & Acquisitions (6)
- Real Estate (1)
- Uncategorized (28)
- Separation and Distribution Agreement, dated as of December 6, 2020, by and between Neurotrope, Inc. and Neurotrope Bioscience, Inc (Filed With SEC on December 7, 2020)
- Tax Matters Agreement, dated as of December 6, 2020, by and between Neurotrope, Inc. and Neurotrope Bioscience, Inc (Filed With SEC on December 7, 2020)
- Second Amendment to Agreement and Plan of Merger, dated as of September 30, 2020, by and between Petros Pharmaceuticals, Inc., PM Merger Sub 1, LLC, PN Merger Sub 2, Inc.,... (Filed With SEC on September 30, 2020)
- Form of the Amended and Restated Series E Warrant (Filed With SEC on September 30, 2020)
- Form of the Amended and Restated Series F Warrant (Filed With SEC on September 30, 2020)
- Form of the Amended and Restated Series G Warrant (Filed With SEC on September 30, 2020)
- Form of the Amended and Restated Series H Warrant (Filed With SEC on September 30, 2020)
- Form of Series A Common Stock Warrant (Series E Spin-Off Warrant) (Filed With SEC on September 30, 2020)
- Form of Series B Common Stock Warrant (Series F Spin-Off Warrant) (Filed With SEC on September 30, 2020)
- Form of Series C Common Stock Warrant (Series G Spin-Off Warrant) (Filed With SEC on September 30, 2020)
- Form of Series D Common Stock Warrant (Series H Spin-Of Warrant) (Filed With SEC on September 30, 2020)
- Form of Voting Agreement by and between Metuchen and certain stockholders of Neurotrope (Filed With SEC on September 30, 2020)
- Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series E warrants (Filed With SEC on September 30, 2020)
- Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series F warrants (Filed With SEC on September 30, 2020)
- Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series G warrants (Filed With SEC on September 30, 2020)
- Warrant Amendment Agreement, dated as of September 29, 2020, by and between Neurotrope, Inc. and the holders of Series H warrants (Filed With SEC on September 30, 2020)
- Services Agreement, by and between Worldwide Clinical Trials, Inc. and Neurotrope BioScience Inc., dated as of July 23, 2020 (Filed With SEC on July 29, 2020)
- First Amendment to Agreement and Plan of Merger, dated as of July 23, 2020, by and between Petros Pharmaceuticals, Inc., PM Merger Sub 1, LLC, PN Merger Sub 2, Inc., Neurotrope,... (Filed With SEC on July 24, 2020)
- Employee Lease Agreement, dated as of July 23, 2020, by and between Neurotrope, Inc., Neurotrope Bioscience, Inc. and Metuchen Pharmaceuticals, LLC (Filed With SEC on July 24, 2020)
- Supply Agreement, dated as of June 9, 2020, by and between the Company and BryoLogyx Inc (Filed With SEC on June 12, 2020)
- Transfer Agreement, dated as of June 9, 2020, by and between the Company and BryoLogyx Inc (Filed With SEC on June 12, 2020)
- Agreement and Plan of Merger and Reorganization, dated as of May 17, 2020, by and among Petros, Neurotrope, Merger Sub 1, Merger Sub 2 and Metuchen (Filed With SEC on May 18, 2020)
- Form of Neurotrope Voting Agreement, by and between Metuchen and certain stockholders of Neurotrope (Filed With SEC on May 18, 2020)
- Form of Metuchen Voting Agreement, by and between Neurotrope and certain unitholders of Metuchen (Filed With SEC on May 18, 2020)
- Form of Lock-Up Agreement, by and between Petros, Neurotrope, Metuchen and certain securityholders of Neurotrope and Metuchen (Filed With SEC on May 18, 2020)
- Description of the Registrants securities (Filed With SEC on March 13, 2020)
- Form of Series H Common Stock Purchase Warrant (Filed With SEC on January 23, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on January 23, 2020)
- Consulting Advisory Agreement dated as of January 22, 2020, by and between the Company and Katalyst Securities, LLC (Filed With SEC on January 23, 2020)
- Separation Agreement, dated October 23, 2019, between Neurotrope, Inc., Neurotrope Bioscience, Inc. and Michael F. Ciraolo, J.D., Ph.D (Filed With SEC on October 25, 2019)
- Rights Agreement, dated as of September 9, 2019, between Neurotrope, Inc. and Philadelphia Stock Transfer, Inc., as rights agent (Filed With SEC on September 9, 2019)
- Employment Agreement, dated March 29, 2019, between Neurotrope, Inc. and Michael Ciraolo (Filed With SEC on April 1, 2019)
- Amendment to Placement Agent Agreement, dated as of December 21, 2018, by and between the Company and GP Nurmenkari Inc (Filed With SEC on December 31, 2018)
- Amendment to Advisory Consulting Agreement, dated as of December 31, 2018, by and between the Company and Maxim Group LLC (Filed With SEC on December 31, 2018)
- Amendment to Advisory Consulting Agreement, dated as of December 21, 2018, by and between the Company and Katalyst Securities LLC (Filed With SEC on December 31, 2018)
- Form of Series G Common Stock Purchase Warrant (Filed With SEC on December 17, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on December 17, 2018)
- Form of Consulting Agreement (Filed With SEC on December 17, 2018)
- Placement Agent Agreement dated as of December 17, 2018, by and between the Company and GP Nurmenkari Inc (Filed With SEC on December 17, 2018)
- Form of Second Amendment to Amended and Restated Technology License and Services Agreement among Neurotrope BioScience, Inc., Cognitive Research Enterprises, Inc. and NRV II, LLC,... (Filed With SEC on December 4, 2018)
- Services Agreement by and between Worldwide Clinical Trials, Inc. and Neurotrope BioScience Inc., dated as of May 4, 2018 (Filed With SEC on May 10, 2018)
- Separation Agreement, dated December 14, 2017, between Neurotrope, Inc., Neurotrope Bioscience, Inc. and Susanne Wilke, Ph.D (Filed With SEC on December 18, 2017)
- Employment Agreement, dated December 14, 2017, between Neurotrope, Inc. and Charles Ryan (Filed With SEC on December 18, 2017)
- NEUROTROPE, INC. 2017 EQUITY INCENTIVE PLAN (Filed With SEC on April 14, 2017)
- NEUROTROPE, INC. Form of Stock Option Grant Notice Stock Option Grant under the Company’s 2017 Equity Incentive Plan (Filed With SEC on April 14, 2017)
- FORM OF INDEMNITYAGREEMENT (Filed With SEC on March 10, 2017)
- NEUROTROPE, INC. NONEMPLOYEEDIRECTOR COMPENSATION POLICY (AdoptedMarch 9, 2017) (Filed With SEC on March 10, 2017)
- AMENDMENTNO. 2 TO NEUROTROPE, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on November 23, 2016)
- Form of Series F Warrants (Filed With SEC on November 18, 2016)
- FORM OF AMENDMENT TO SERIESA WARRANT to Purchase COMMON STOCK OF NEUROTROPE, INC. (Filed With SEC on November 18, 2016)
- FORM OF AMENDMENT TO SERIESC WARRANT to Purchase COMMON STOCK OF NEUROTROPE, INC. (Filed With SEC on November 18, 2016)
- FORM OF AMENDMENT TO SERIESE WARRANT to Purchase COMMON STOCK OF NEUROTROPE, INC. (Filed With SEC on November 18, 2016)
- BROKER WARRANT (Filed With SEC on November 18, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 18, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 18, 2016)
- FORM OF AMENDMENT TO SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 18, 2016)
- KATALYST SECURITIES LLC 1330 AVENUE OF THE AMERICAS, 14THFLOOR NEW YORK, NY 10019 TEL: 212 ###-###-#### Member: FINRA & SIPC GP NUREMENKARI INC. 18 EAST 41ST STREET, SUITE 1902... (Filed With SEC on November 18, 2016)
- SEPARATION AGREEMENT (Filed With SEC on August 5, 2016)
- [Signature Page Follows] (Filed With SEC on August 5, 2016)
- [Signature Page Follows] (Filed With SEC on August 5, 2016)
- COMPANY CONSULTING AGREEMENT (Filed With SEC on August 5, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 19, 2015)
- Form of Series A Warrants (Filed With SEC on November 19, 2015)
- Form of Series B Warrants (Filed With SEC on November 19, 2015)
- Form of Series C Warrants (Filed With SEC on November 19, 2015)
- Form of Series D Warrants (Filed With SEC on November 19, 2015)
- Form of Series E Warrants (Filed With SEC on November 19, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 19, 2015)
- FORM OF PENNY BROKERWARRANT WARRANT (Filed With SEC on November 19, 2015)
- FORM OF IV BROKERWARRANT WARRANT (Filed With SEC on November 19, 2015)
- FORM OF INSTITUTIONALBROKER WARRANT WARRANT (Filed With SEC on November 19, 2015)
- NEUROTROPE, INC. AMENDMENT NO. 2 TO PREFERRED STOCKHOLDERS AGREEMENT (Filed With SEC on November 19, 2015)
- AMENDMENTTO AMENDEDAND RESTATED TECHNOLOGYLICENSE AND SERVICE AGREEMENT (Filed With SEC on November 13, 2015)
- [Signature page follows] (Filed With SEC on November 13, 2015)
- Statement of Work Agreement (Filed With SEC on November 13, 2015)
- SERVICES AGREEMENT (Filed With SEC on October 15, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 28, 2015)
- COMPANY CONSULTING AGREEMENT (Filed With SEC on March 26, 2015)
- AMENDEDAND RESTATED TECHNOLOGYLICENSE AND SERVICES AGREEMENT by and between NEUROTROPE BIOSCIENCE,INC., on the one hand, and BLANCHETTE ROCKEFELLERNEUROSCIENCES INSTITUTE and NRV... (Filed With SEC on February 10, 2015)
- Statement of Work and Account SatisfactionAgreement (Filed With SEC on February 10, 2015)
- CONVERSION AGREEMENT (Filed With SEC on February 10, 2015)
- PLACEMENT AGENT WARRANT (Filed With SEC on February 10, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 6, 2014)
- CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on October 10, 2014)
- NEUROTROPE, INC. AMENDMENT NO. 1 TO PREFERRED STOCKHOLDERS AGREEMENT (Filed With SEC on September 5, 2014)
- AMENDMENT NO. 1 TO THE NEUROTROPE, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 9, 2013)
- ASSIGNMENT OF AND AMENDMENT TO PLACEMENT AGENT AGREEMENT (Filed With SEC on October 9, 2013)
- ______________________________________________________________________ AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among NEUROTROPE, INC. (formerly BlueFlash Communications,... (Filed With SEC on August 29, 2013)
- SPLIT-OFF AGREEMENT (Filed With SEC on August 29, 2013)
- GeneralRELEASE agreement (Filed With SEC on August 29, 2013)
- LOCK-UP AGREEMENT (Filed With SEC on August 29, 2013)
- NEUROTROPEBIOSCIENCE, INC. SUBSCRIPTION BOOKLET FOR SERIES A PREFERRED STOCK (Filed With SEC on August 29, 2013)
- PLACEMENT AGENT WARRANT (Filed With SEC on August 29, 2013)
- PLACEMENT AGENT WARRANT (Filed With SEC on August 29, 2013)
- Member FINRA, SIPC PLACEMENT AGREEMENT (Filed With SEC on August 29, 2013)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 29, 2013)
- CONSULTINGAGREEMENT (Filed With SEC on August 29, 2013)
- NEUROTROPE, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on August 29, 2013)
- STOCK OPTION AGREEMENT NEUROTROPE, INC. (Filed With SEC on August 29, 2013)
- AGREEMENT AND PLAN OF MERGER (Filed With SEC on August 8, 2013)
- AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on August 8, 2013)
